Multi-metabolites platform for diagnosis of acute coronary syndrome

A kit for diagnosis of acute coronary syndrome, comprising:

• a detector configured to detect in-vivo level of one or more metabolite selected from a group consisting of tryptophan, homoserine, phosphatidylcholine (PC) (34:2), PC (34:3), lysophosphatidylcholine (lysoPC) (16:0), lysoPC (20:4), lysoPC (22:6), monoglyceride (18:1/0:0/0:0) and sphingomyelin (d18:2/16:0) from a sample,
• a composition comprising tryptophan, homoserine, phosphatidylcholine (PC) (34:2), PC (34:3), lysophosphatidylcholine (lysoPC) (16:0), lysoPC (20:4), lysoPC (22:6), monoglyceride (18:1/0:0/0:0) and sphingomyelin (d18:2/16:0) in a control level corresponding to normal control group of healthy people without the acute coronary syndrome;
• a multivariate analysis system configured to analyze a difference in the in-vivo level of the one or more metabolite and the control level, and
• an instruction for an acute coronary syndrome diagnosis method,
• wherein the method comprises:
• measuring, using the in-vivo level detector, the level of the one or more metabolite from a sample, wherein the sample comprises a biological fluid taken from a patient, to obtain a patient metabolite level;
• and
• comparing the patient metabolite level to a normal control group level of the one or more metabolite.